Does vertebral bone marrow fat content correlate with abdominal adipose tissue, lumbar spine bone mineral density, and blood biomarkers in women with type 2 diabetes mellitus?

Journal of Magnetic Resonance Imaging

Volumn 35, Issue 1, 2012, Pages 117-124

  Baum, Thomas ^a   Yap, Samuel P ^a   Karampinos, Dimitrios C ^a   Nardo, Lorenzo ^a   Kuo, Daniel ^a   Burghardt, Andrew J ^a   Masharani, Umesh B ^b   Schwartz, Ann V ^a   Li, Xiaojuan ^a   Link, Thomas M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

abdominal adipose tissue; bone mineral density; diabetes; MR spectroscopy; quantitative computed tomography; vertebral bone marrow fat

Indexed keywords

BIOLOGICAL MARKER; CALCIUM; GLUCOSE; HEMOGLOBIN A1C; PARATHYROID HORMONE; VITAMIN D;

ABDOMINAL FAT; ABDOMINAL OBESITY; ADIPOSE TISSUE; ADULT; AGED; ARTICLE; BLOOD LEVEL; BONE DENSITY; BONE MARROW; BONE MINERAL; CALCIUM BLOOD LEVEL; CLINICAL ARTICLE; COMPUTED TOMOGRAPHY SCANNER; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; LUMBAR SPINE; MULTIDETECTOR COMPUTED TOMOGRAPHY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PARATHYROID HORMONE BLOOD LEVEL; PHANTOM; POSTMENOPAUSE; POSTMENOPAUSE OSTEOPOROSIS; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; VERTEBRA; VITAMIN BLOOD LEVEL;

ABDOMINAL FAT; ADIPOSE TISSUE; AGED; BIOLOGICAL MARKERS; BONE DENSITY; BONE MARROW; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; LUMBAR VERTEBRAE; MAGNETIC RESONANCE SPECTROSCOPY; MIDDLE AGED; POSTMENOPAUSE; REPRODUCIBILITY OF RESULTS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 83755206243     PISSN: 10531807     EISSN: 15222586     Source Type: Journal    
DOI: 10.1002/jmri.22757     Document Type: Article

References (41)

1. Gallagher D, Kelley DE, Yim JE, et al. Adipose tissue distribution is different in type 2 diabetes. Am J Clin Nutr 2009; 89: 807-814.
2. Hamdy O, Porramatikul S, Al Ozairi E,. Metabolic obesity: the paradox between visceral and subcutaneous fat. Curr Diabetes Rev 2006; 2: 367-373. (Pubitemid 44734225)
3. Heshka S, Ruggiero A, Bray GA, et al. Altered body composition in type 2 diabetes mellitus. Int J Obes (Lond) 2008; 32: 780-787. (Pubitemid 351670625)
4. Dulloo AG, Jacquet J, Solinas G, Montani JP, Schutz Y,. Body composition phenotypes in pathways to obesity and the metabolic syndrome. Int J Obes (Lond) 2010; 34 (Suppl 2): S4-S17.
5. World Health Organization. Definition, diagnosis and classification of diabetes mellitus and its complications. Geneva: WHO; 1999.
6. Bredella MA, Torriani M, Ghomi RH, et al. Vertebral bone marrow fat is positively associated with visceral fat and inversely associated with IGF-1 in obese women. Obesity (Silver Spring) 2011; 19: 49-53.
7. Griffith JF, Yeung DK, Antonio GE, et al. Vertebral marrow fat content and diffusion and perfusion indexes in women with varying bone density: MR evaluation. Radiology 2006; 241: 831-838. (Pubitemid 46190550)
8. Yoshizumi T, Nakamura T, Yamane M, et al. Abdominal fat: standardized technique for measurement at CT. Radiology 1999; 211: 283-286. (Pubitemid 29161765)
9. Schellinger D, Lin CS, Hatipoglu HG, Fertikh D,. Potential value of vertebral proton MR spectroscopy in determining bone weakness. AJNR Am J Neuroradiol 2001; 22: 1620-1627. (Pubitemid 32862282)
10. Machann J, Thamer C, Stefan N, et al. Follow-up whole-body assessment of adipose tissue compartments during a lifestyle intervention in a large cohort at increased risk for type 2 diabetes. Radiology 2010; 257: 353-363.
11. Bredella MA, Fazeli PK, Miller KK, et al. Increased bone marrow fat in anorexia nervosa. J Clin Endocrinol Metab 2009; 94: 2129-2136.
12. Masala S, Massari F, Assako OP, et al. Is 3T-MR spectroscopy a predictable selection tool in prophylactic vertebroplasty? Cardiovasc Intervent Radiol 2010; 33: 1243-1252.
13. Oriol A, Valverde D, Capellades J, Cabanas ME, Ribera JM, Arus C,. In vivo quantification of response to treatment in patients with multiple myeloma by 1H magnetic resonance spectroscopy of bone marrow. MAGMA 2007; 20: 93-101. (Pubitemid 46684542)
14. Rosen CJ, Ackert-Bicknell C, Rodriguez JP, Pino AM,. Marrow fat and the bone microenvironment: developmental, functional, and pathological implications. Crit Rev Eukaryot Gene Expr 2009; 19: 109-124.
15. Botolin S, McCabe LR,. Bone loss and increased bone adiposity in spontaneous and pharmacologically induced diabetic mice. Endocrinology 2007; 148: 198-205. (Pubitemid 46021451)
16. Nelson SJ,. Analysis of volume MRI and MR spectroscopic imaging data for the evaluation of patients with brain tumors. Magn Reson Med 2001; 46: 228-239. (Pubitemid 32703267)
17. Li X, Youngren JF, Hyun B, et al. Technical evaluation of in vivo abdominal fat and IMCL quantification using MRI and MRSI at 3 T. Magn Reson Imaging 2008; 26: 188-197.
18. Li X, Kuo D, Schafer AL, et al. Quantification of vertebral bone marrow fat content using 3 tesla MR spectroscopy: reproducibility, vertebral variation, and applications in osteoporosis. J Magn Reson Imaging 2011; 33: 974-979.
19. Li X, Nelson SJ,. Reliable in vivo lactate and lipid estimation in glioma patients. In: Proceedings of the 25th Annual International Conference of IEEE Engineering in Medicine and Biology Society (EMBS), Cancun, Mexico, 2003.
20. Gluer CC, Blake G, Lu Y, Blunt BA, Jergas M, Genant HK,. Accurate assessment of precision errors: how to measure the reproducibility of bone densitometry techniques. Osteoporos Int 1995; 5: 262-270.
21. Goodpaster BH, Krishnaswami S, Resnick H, et al. Association between regional adipose tissue distribution and both type 2 diabetes and impaired glucose tolerance in elderly men and women. Diabetes Care 2003; 26: 372-379. (Pubitemid 36929058)
22. Stewart KJ, Deregis JR, Turner KL, et al. Fitness, fatness and activity as predictors of bone mineral density in older persons. J Intern Med 2002; 252: 381-388. (Pubitemid 36706569)
23. Reid IR,. Fat and bone. Arch Biochem Biophys 2010; 503: 20-27.
24. Gilsanz V, Chalfant J, Mo AO, Lee DC, Dorey FJ, Mittelman SD,. Reciprocal relations of subcutaneous and visceral fat to bone structure and strength. J Clin Endocrinol Metab 2009; 94: 3387-3393.
25. Zillikens MC, Uitterlinden AG, van Leeuwen JP, et al. The role of body mass index, insulin, and adiponectin in the relation between fat distribution and bone mineral density. Calcif Tissue Int 2010; 86: 116-125.
26. von Muhlen D, Safii S, Jassal SK, Svartberg J, Barrett-Connor E,. Associations between the metabolic syndrome and bone health in older men and women: the Rancho Bernardo Study. Osteoporos Int 2007; 18: 1337-1344. (Pubitemid 47389466)
27. Griffith JF, Yeung DK, Antonio GE, et al. Vertebral bone mineral density, marrow perfusion, and fat content in healthy men and men with osteoporosis: dynamic contrast-enhanced MR imaging and MR spectroscopy. Radiology 2005; 236: 945-951. (Pubitemid 41170858)
28. Tang GY, Lv ZW, Tang RB, et al. Evaluation of MR spectroscopy and diffusion-weighted MRI in detecting bone marrow changes in postmenopausal women with osteoporosis. Clin Radiol 2010; 65: 377-381.
29. Blake GM, Griffith JF, Yeung DK, Leung PC, Fogelman I,. Effect of increasing vertebral marrow fat content on BMD measurement, T-score status and fracture risk prediction by DXA. Bone 2009; 44: 495-501.
30. Yeung DK, Griffith JF, Antonio GE, Lee FK, Woo J, Leung PC,. Osteoporosis is associated with increased marrow fat content and decreased marrow fat unsaturation: a proton MR spectroscopy study. J Magn Reson Imaging 2005; 22: 279-285. (Pubitemid 41045443)
31. Cheng AY, Leiter LA,. Diabetes and cardiovascular disease: the role of glycemic control. Curr Diab Rep 2009; 9: 65-72.
32. Cheng AY, Leiter LA,. Glucose lowering and cardiovascular disease: what do we know and what should we do? Eur J Cardiovasc Prev Rehabil 2010; 17 (Suppl 1): S25-S31.
33. Inoue K, Matsumoto M, Akimoto K,. Fasting plasma glucose and HbA1c as risk factors for type 2 diabetes. Diabet Med 2008; 25: 1157-1163.
34. Maynard JD, Rohrscheib M, Way JF, Nguyen CM, Ediger MN,. Noninvasive type 2 diabetes screening: superior sensitivity to fasting plasma glucose and A1C. Diabetes Care 2007; 30: 1120-1124. (Pubitemid 46684635)
35. Bennett CM, Guo M, Dharmage SC,. HbA(1c) as a screening tool for detection of type 2 diabetes: a systematic review. Diabet Med 2007; 24: 333-343. (Pubitemid 46452406)
36. Kramer CK, Araneta MR, Barrett-Connor E,. A1C and diabetes diagnosis: the Rancho Bernardo study. Diabetes Care 2010; 33: 101-103.
37. Kuchuk NO, van Schoor NM, Pluijm SM, Chines A, Lips P,. Vitamin D status, parathyroid function, bone turnover, and BMD in postmenopausal women with osteoporosis: global perspective. J Bone Miner Res 2009; 24: 693-701.
38. von Muhlen DG, Greendale GA, Garland CF, Wan L, Barrett-Connor E,. Vitamin D, parathyroid hormone levels and bone mineral density in community-dwelling older women: the Rancho Bernardo study. Osteoporos Int 2005; 16: 1721-1726. (Pubitemid 41790881)
39. Hoffman RP,. Metabolic syndrome racial differences in adolescents. Curr Diabetes Rev 2009; 5: 259-265.
40. McNabb W, Quinn M, Tobian J,. Diabetes in African American women: the silent epidemic. Womens Health 1997; 3: 275-300.
41. Potretzke AM, Schmitz KH, Jensen MD,. Preventing overestimation of pixels in computed tomography assessment of visceral fat. Obes Res 2004; 12: 1698-1701. (Pubitemid 41132479)